Literature DB >> 104795

Determination of meningococcal antibodies by microassay.

F Ambrosch, H Stemberger, G Wiedermann, G Stanek, D Jovanovic.   

Abstract

A modified microassay procedure, using triphenyltetrazolium chloride as a germination indicator, was compared with a macroassay method proposed by the World Health Organization for determining the level of antibodies before and after immunization with Group A meningococcal polysaccharide vaccine. There was excellent agreement between the results obtained by the two methods. The vaccine used appeared to be safe and immunogenic.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 104795      PMCID： PMC2395666     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  4 in total

1.  Clinical and laboratory investigations of monovalent and combined meningococcal polysaccharide vaccine, groups A and C.

Authors:  R E Weibel; V M Villarejos; P P Vella; A F Woodhour; A A Mclean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1976-12

2.  Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.

Authors:  R Gold; M L Lepow; I Goldschneider; T L Draper; E C Gotschlich
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

3.  Effect of group-A meningococcal vaccine in army recruits in Finland.

Authors:  P H Mäkelä; H Käyhty; P Weckström; A Sivonen; O V Renkonen
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

4.  Meningococcal infections. 4. Stability of group A and group C polysaccharide vaccines.

Authors:  M S Artenstein
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408
  4 in total
  1 in total

1.  Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.

Authors:  F Ambrosch; G Wiedermann; P Crooy; A M George
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.